| Date Checked | 2025-12-21 23:19:38 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 4.48% |
| Dividend Date | 2025-12-15 |
| Symbol | VTRS |
| AssetType | Common Stock |
| Name | Viatris Inc |
| Description | Viatris Inc. (VTRS) is a leading global healthcare company based in Canonsburg, Pennsylvania, resulting from the strategic merger of Mylan and Upjohn, a division of Pfizer. With a diverse portfolio that includes generic, branded, and over-the-counter medications, Viatris is committed to increasing access to high-quality healthcare in over 165 countries. The company focuses on addressing a wide range of health challenges and improving patient outcomes through innovation and an extensive distribution network. As it adapts to the evolving healthcare landscape, Viatris is dedicated to providing cost-effective solutions that enhance healthcare systems and ensure long-term sustainability. |
| CIK | 1792044 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Address | ROBERT J. COURY GLOBAL CENTER, CANONSBURG, PA, UNITED STATES, 15317 |
| OfficialSite | https://www.viatris.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 12514425000 |
| EBITDA | 4037300000 |
| PERatio | 0 |
| PEGRatio | 0.144 |
| BookValue | 13.13 |
| DividendPerShare | 0.48 |
| EPS | -3.13 |
| RevenuePerShareTTM | 11.96 |
| ProfitMargin | -0.261 |
| OperatingMarginTTM | 0.108 |
| ReturnOnAssetsTTM | 0.0218 |
| ReturnOnEquityTTM | -0.211 |
| RevenueTTM | 14124400000 |
| GrossProfitTTM | 5659300000 |
| DilutedEPSTTM | -3.13 |
| QuarterlyEarningsGrowthYOY | -0.706 |
| QuarterlyRevenueGrowthYOY | 0.002 |
| AnalystTargetPrice | 12.12 |
| AnalystRatingStrongBuy | 1 |
| AnalystRatingBuy | 3 |
| AnalystRatingHold | 5 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | - |
| ForwardPE | 4.372 |
| PriceToSalesRatioTTM | 0.886 |
| PriceToBookRatio | 0.811 |
| EVToRevenue | 1.834 |
| EVToEBITDA | 11.16 |
| Beta | 0.837 |
| 52WeekHigh | 12.5 |
| 52WeekLow | 6.6 |
| 50DayMovingAverage | 10.28 |
| 200DayMovingAverage | 9.47 |
| SharesOutstanding | 1151770000 |
| SharesFloat | 1144030000 |
| PercentInsiders | 0.279 |
| PercentInstitutions | 86.837 |
| ExDividendDate | 2025-11-24 |
| etoro | 1 |
| dateChecked | 2025-12-21 23:19:38 |
| fresh | 1 |